Since we showed in our cell fractionation assay that DRAIC was predominantly expressed in the cytoplasm of prostate cancer cells [8], several molecular mechanisms as a cytoplasmic lncRNA have been reported [9,10,14,15,35]. Here, DRAIC is linked to prostate cancer.